METHOD FOR TREATING RESISTANT HUMAN TUMORS WITH EPIDERMIS GROWTH FACTOR RECEPTORS ANTAGONISTS Russian patent published in 2007 - IPC A61K39/395 A61K39/44 A61K31/282 A61P35/00

Abstract RU 2294761 C2

FIELD: medicine.

SUBSTANCE: method involves applying effective doses of epidermis growth factor receptors antagonists being active ingredient in drug for inhibiting various types of resistant human tumors. The epidermis growth factor receptor antagonists are combined with other chemotherapeutic agents like Cisplatin, Irinotecan or ionizing radiation.

EFFECT: enhanced effectiveness of treatment.

50 cl, 2 tbl

Similar patents RU2294761C2

Title	Year	Author	Number
NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING MALIGNANT GROWTH	2011	Dzhekson Erika Svit-Kordero Erik Alekhandro	RU2587619C2
MEANS OF IDENTIFICATION OF TUMOURS, ACQUISITIVE TO TREATMENT BY ANTIBODIES AGAINST ErbB2	2003	Koll' Khans Bossenmajer Birgit Mjuller Khans-Joakhim Slivkovski Mark K. Kelsi Stefen Majkl	RU2338751C2
RECEPTOR ANTAGONISTS FOR TREATING METASTATIC CANCER	2009	Loizos Nik Kh'Juber Dzhim	RU2455026C2
PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR	2006	Ljudvig Dejl L. Plajmejt Stefen R. Loizos Nik Kh'Juber Dzhim Fatatis Alessandro	RU2502523C2
METHOD FOR RECEPTOR TYROSINE KINASE INHIBITION WITH USE EXTRACELLULAR ANTAGONIST AND INTRACELLULAR ANTAGONIST	2004	Vaksal Samuehl'	RU2431500C2
ANTI-ANGIOGENESIS THERAPY FOR TREATING PREVIOUSLY TREATED BREAST CANCER	2010	Svami, Radzheshvari Khamblton, Dzhuli	RU2576027C2
PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS	2003	Krejsh Khans-Georg Shmidt Jurgen	RU2354402C2
MULTISPECIFIC ANTIBODIES, THEREOF ANALOGUES, COMPOSITIONS AND METHODS	2010	Sheer Dzhastin Vandlen Richard L.	RU2580038C2
COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS	2001	Gudman Sajmon Krejsh Khans-Georg	RU2292904C2
COMPOSITIONS AND METHODS OF TREATING AND DIAGNOSING CANCER-RESISTANT CANCER	2015	Wang, Yulei	RU2710735C2

RU 2 294 761 C2

Authors

Uaksal Kharlen U.

Dates

2007-03-10—Published

2000-05-01—Filed